2017

150.00 rub.
Buy article
2017/№1

Key factors determining the risk of recurrent myocardial infarction

Barbarash O. L., Sedykh D. Yu., Gorbunova E. V.
Federal State Budgetary Institution "Research Institute for Complex Issues of Cardiovascular Diseases", Federal Agency for Scientific Organizations, Sosnovy Bulvar 6, Kemerovo 650002

Keywords: risk factors, recurrent myocardial infarction, treatment compliance

DOI: 10.18087/rhj.2017.1.2280

Background. Multiple clinical studies have demonstrated the significance of evaluating and managing the risk for recurrent ischemic events. Aim. To evaluate risk factors for recurrent myocardial infarction (MI) for 5 years. Materials and methods. As a part of the acute coronary syndrome registry at the Municipal Budgetary Institution of Health Care, “Kemerovo Cardiology Center” in 2009, the study included 471 patients (333 (70.7%) men aged 58.8+5.7 at the time of primary MI) with diagnosed primary MI. Incidence of recurrent MI and major factors determining its risk were evaluated during a 5‑year observation period. Results. Recurrent MI was observed in 125 (26.5%) study patients; recurrent MI was fatal for 23 (18.4%) patients. Patients with recurrent MI were older, two times more frequently had hypodynamia, three times more frequently had manifestations of multifocal atherosclerosis in the form of cerebral atherosclerosis and lower‑extremity atherosclerosis, and had lower levels of education and social wellbeing. Patients with recurrent MI less frequently achieved goal values of controlled cardiovascular markers (lipid profile, weight loss, smoking cessation). Conclusion.Measures aimed at increasing patients’ compliance with medical recommendations should be enhanced.
  1. Sanfelix‑Gimeno G, Peiro S, Ferreros I, Perez‑Vicente R , Librero J, Catala‑Lopez F et al. Adherence to evidence‑based therapies after acute coronary syndrome: a retrospective population‑based cohort study linking hospital, outpatient, and pharmacy health information system in Valencia, Spain. J Manag Care Pharm. 2013 Apr;19 (3):247–57.
  2. Kostis WJ, Deng Y, Pantazopoulos JS, Moreyra AE, Kostis JB. Trends in mortality of acute myocardial infarction after discharge from the hospital. Circ Cardiovasc Qual Outcomes. 2010 Nov;3 (6):581–9.
  3. Chung SC, Gedeborg R, Nicholas O, James S, Jeppsson A, Wolfe C et al. Acute myocardial infarction: a comparison of short‑term survival in national outcome registries in Sweden and in the UK. Lancet. 2014 Apr 12;383 (9925):1305–12.
  4. Shah NS, Huffman MD, Ning H, Lloyd‑Jones DM. Trends in myocardial infarction secondary prevention: The National Health and Nutritional Examination Survey (NHANES), 1999–2012. J Am Heart Assoc. 2015 Apr 22;4 (4):pii:e001709.
  5. Peeters A, Mamun AA, Willekens F, Bonneux L. A cardiovascular life history. A life course analysis of the original Framingham Heart Study cohort. Eur Heart J. 2002 Mar;23 (6):458–66.
  6. Bhatt DL, Eagle KA, Ohman EM, Hirsch AT, Goto S, Mahoney EM et al. JAMA. 2010 Sep 22;304 (12):1350–7.
  7. Jernberg T, Hasvold P, Henriksson M, Hjelm H, Thuresson M, Janzon M. Cardiovascular risk in post‑myocardial infarction patients: nationwide real world data demonstrate the importance of long‑term perspective. Eur Heart J. 2015 May 14;36 (19):1163–70.
  8. Бойцов С.А., Довгалевский П.Я., Гриднев В.И., Ощепкова Е.В., Дмитриев В.А. Сравнительный анализ данных российского и зарубежных регистров острого коронарного синдрома. Кардиологический вестник. 2010; V (1):82–6 [Bojczov S.A., Dovgalevskij P.Ya., Gridnev V.I., Oshhepkova E.V., Dmitriev V.A. Sravnitel`ny`j analiz danny`x rossijskogo i zarubezhny`x registrov ostrogo koronarnogo sindroma. Kardiologicheskij vestnik. 2010; V (1):82–6].
  9. Бойцов С.А. Профилактика неинфекционных заболеваний в стране: от «что делать» к «как делать». Профилактическая медицина. 2012;15 (2):3–10 [Bojczov S.A. Profilaktika neinfekczionny`x zabolevanij v strane: ot «chto delat`» k «kak delat`». Profilakticheskaya mediczina. 2012;15 (2):3–10].
  10. Федеральная служба государственной статистики (Росстат). Россия 2015 Статистический справочник. – Р76 Росстат. – М., 2015. – 62с [Federal`naya sluzhba gosudarstvennoj statistiki (Rosstat). Rossiya 2015 Statisticheskij spravochnik. – R76 Rosstat. – M., 2015. – 62s].
  11. Naderi SH, Bestwick JP, Wald DS. Adherence to drugs that prevent cardiovascular disease: meta‑analysis on 376,162 patients. Am J Med. 2012 Sep;125 (9):882–7.e1.
  12. Fox KA, Carruthers KF, Dunbar DR , Graham C, Manning JR, De Raedt H et al. Underestimated and underrecognized: the late consequences of acute coronary syndrome (GRACE UK‑Belgian Study). Eur Heart J. 2010 Nov;31 (22):2755–64.
  13. Округин С.А., Гарганеева А.А., Кужелева Е.А., Борель К.Н. Оценка влияния инфаркта миокарда в анамнезе и предынфарктного состояния на продолжительность догоспитального этапа острого инфаркта миокарда. Комплексные проблемы сердечно‑сосудистых заболеваний. 2016;5 (1):55–9 [Okrugin S.A., Garganeeva A.A., Kuzheleva E.A., Borel` K.N. Oczenka vliyaniya infarkta miokarda v anamneze i predy`nfarktnogo sostoyaniya na prodolzhitel`nost` dogospital`nogo e`tapa ostrogo infarkta miokarda. Kompleksny`e problemy` serdechno‑sosudisty`x zabolevanij. 2016;5 (1):55–9].
  14. Sorenzen R , Gislason GH, Fosbol EL, Rasmussen S, Kober L, Madsen JK et al. Initiation and persistence with clopidogrel treatment after acute myocardial infarction: a nationwide study. Br J Clin Pharmacol. 2008 Dec;66 (6):875–84.
  15. Gislason GH, Rasmussen JN, Abildstrom SZ, Gadsboll N, Buch P, Friberg J et al. Long‑term compliance with beta‑blockers, angioten‑sin‑converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J. 2006 May;27 (10):1153–8.
  16. Эрлих А.Д. Двойная антитромбоцитарная терапия: необходимость приверженности к лечению и возможности ее повышения. Атеротромбоз. 2014;2:25–33 [E`rlix A.D. Dvojnaya antitromboczitarnaya terapiya: neobxodimost` priverzhennosti k lecheniyu i vozmozhnosti ee povy`sheniya. Aterotromboz. 2014;2:25–33].
  17. Эрлих А.Д., Грацианский Н.А. Регистр РЕКОРД. Лечение больных с острыми коронарными синдромами в стационарах, имеющих и не имеющих возможности выполнения инвазивных коронарных процедур. Кардиология. 2010;50 (7):15–20 [E`rlix A. D., Graczianskij N.A. Registr REKORD. Lechenie bol`ny`x s ostry`mi koronarny`mi sindromami v staczionarax, imeyushhix i ne imeyushhix vozmozhnosti vy`polneniya invazivny`x koronarny`x proczedur. Kardiologiya. 2010;50 (7):15–20].
  18. Эрлих А.Д., Харченко М.С., Барбараш О.Л., Кашталап В.В., Зыков М.В., Печерина Т.Б. и др. Степень приверженности к выполнению руководств по лечению острого коронарного синдрома в клинической практике российских стационаров и исходы в период госпитализации (данные регистра РЕКОРД‑2). Кардиология. 2013;53 (2):14–22 [E`rlix A. D., Xarchenko M.S., Barbarash O.L., Kashtalap V.V., Zy`kov M. V., Pecherina T.B. i dr. Stepen` priverzhennosti k vy`polneniyu rukovodstv po lecheniyu ostrogo koronarnogo sindroma v klinicheskoj praktike rossijskix staczionarov i isxody` v period gospitalizaczii (danny`e registra REKORD‑2). Kardiologiya. 2013;53 (2):14–22].
  19. Толпыгина С.Н., Полянская Ю.Н., Марцевич С.Ю. Лечение пациентов с хронической ИБС в реальной клинической практике по данным регистра ПРОГНОЗ ИБС (часть 2). Рациональная фармакотерапия в кардиологии. 2013;9 (5):494–9 [Tolpy`gina S. N., Polyanskaya Yu.N., Marczevich S.Yu. Lechenie paczientov s xronicheskoj IBS v real`noj klinicheskoj praktike po danny`m registra PROGNOZ IBS (chast` 2). Raczional`naya farmakoterapiya v kardiologii. 2013;9 (5):494–9].
  20. Waters DD, Schwartz GG, Olsson AG, Zeiher A, Oliver MF, Ganz P et al. Effects of atorvastatin on stroke in patients with unstable angina or non‑Q‑wave myocardial infarction: a Myocardial Ischemia reduction with Aggressive Cholesterol Lowering (MIRACL) substudy. Circulation. 2002 Sep 24;106 (13):1690–5.
  21. Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004 Apr 8;350 (15):1495–504.
  22. Алтарев С.С., Барбараш О.Л., Помешкина С.А., Кашталап В.В., Зыков М., Тавлуева Е.В., Барбараш Л.С. Причины отказа от проведения реперфузионной терапии у пациентов с острым коронарным синдромом с подъемом сегмента ST. Кардиология. 2012;52 (6):4–9 [Altarev S.S., Barbarash O.L., Pomeshkina S.A., Kashtalap V.V., Zy`kov M., Tavlueva E.V., Barbarash L.S. Prichiny` otkaza ot provedeniya reperfuzionnoj terapii u paczientov s ostry`m koronarny`m sindromom s pod``emom segmenta ST. Kardiologiya. 2012;52 (6):4–9]
Barbarash O.L., Sedykh D.Yu., Gorbunova E.V. Key factors determining the risk of recurrent myocardial infarction. Russian Heart Journal. 2017;16 (1):26–31.

To access this material please log in or register

Register Authorize
Ru En